Sachetta’s AstraZeneca AZN Stock Holding History

Sachetta’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.53K	Hold	45	–	–	﹤0.01%	483
2026 Q1	$8.88K	Hold	45	–	–	﹤0.01%	469
2025 Q4	$8.27K	Hold	45	–	–	﹤0.01%	442
2025 Q3	$6.91K	Hold	45	–	–	﹤0.01%	537
2025 Q2	$6.29K	Hold	45	–	–	﹤0.01%	535
2025 Q1	$6.62K	Sell	45 -3	-6%	-$434	﹤0.01%	509
2024 Q4	$6.22K	Buy	48 +3	+7%	+$420	﹤0.01%	540
2024 Q3	$7.01K	Hold	45	–	–	﹤0.01%	554
2024 Q2	$7.01K	Sell	45 -103	-70%	-$15.5K	﹤0.01%	516
2024 Q1	$19.9K	Hold	148	–	–	0.01%	309
2023 Q4	$19.9K	Buy	+148	New	+$19.2K	0.01%	309

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Sachetta's AZN Position: Q2 2026 in Review

Sachetta held its AstraZeneca (AZN) position steady in Q2 2026 at 45 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Sachetta first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.9K in Q1 2024. 351 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Sachetta held 45 shares of AstraZeneca worth $8.53K as of Q2 2026.
Sachetta left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #483 holding.
Sachetta first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Sachetta's AstraZeneca position peaked at $19.9K in Q1 2024.
351 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.